Surprisingly, looking at the OS, the only molecular subtypes of GBM that had a OS benefit were shown in those subjects included in the proneural group, unveiling that not only the expression of angiogenic factors may be worth considering in terms of the predictive potential but also the downstream pathways affected by targeting the VEGF signaling [124]. This evidence concerns the gene VEGFA and glioblastoma.